To deliver life-changing wound care solutions to chronic wound patients globally.
To be leaders in chronic wound prevention and management, restoring dignity and quality of life to patients.
Our Primary Indicator: The Unmet Need in Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a condition that causes painful, recurrent lesions to form in delicate areas of the body. These lesions necessitate routine care, especially in challenging regions like the armpit and groin, areas unsuited to the use of adhesive bandages. The wound care industry has, unfortunately, neglected the unique needs of the HS community. Traditional methods have either damaged these wounds further or haven’t been up to the task, leading many patients into distress, isolation, and mental health challenges.
Global prevalence of HS is between 1% and 4 %.
85% of this patient cohort are new to advanced wound care.
Over 50% of people with HS require specialist dressings for over 9 months of the year
Potential $2.4 Billion HS woundcare market in the US and UK alone
Suzanne Moloney, our Founder and CEO, knows the trials of HS firsthand, having lived with the condition since childhood. The initial HidraWear products were born out of her personal need. Recognizing a global challenge, Suzanne engaged with the University of Galway’s BioExel program. Here, experts from various fields collaborated to develop advanced prototypes, kickstart clinical research, and secure initial funding in 2019.
Supported by Enterprise Ireland, the business and team has grown substantially since this time. We have secured reimbursement in the UK, US, and Germany, and have entered distribution agreements in these regions. The feedback from our initial market tests has been exceptional, highlighting benefits not just for patients but also for clinicians.
Our Product Range
Our patented HidraWear range represents a revolutionary approach to wound care. It empowers patients living with wounds in hard to dress areas to self-care, improving their quality of life and driving care efficiency for clinicians.
Our dedication has earned us multiple awards and, more importantly, the gratitude of patients who’ve seen tremendous improvements in their daily lives.
Our Leadership Team is a unique blend of patient insight and deep medical device research, development and commercialisation expertise; committed to transforming the lives of people with HS as well as other chronic wounds in difficult-to-dress areas.
Suzanne Moloney- CEO
Serial entrepreneur. Founder and inventor of HidraWear, Suzanne has first hand experience of living with chronic wounds, and a deep understanding of patient needs.
Phil Cooper- Chair
Phil was Executive President of the Wound Care Division of Molnlycke Healthcare from 2007-2014. His vast experience and knowledge of the wound care industry is invaluable. He now serves as Director and Chair of several medical device companies.
Chris Lane- CCO
Chris is a leader in Wound Care commercialization, with over 25 years in senior leadership roles at major wound care companies including Smith & Nephew and Molnlycke.
Conan Cavanagh- COO
Conan has over 15 years Medical Device Design, Development (Class I, II and III) & 10 years Operational Leadership Experience at Smith and Nephew.
Allan Kennedy- CFO
Strategic and commercially focused CFO with diverse experience across international and domestic markets with multinational, SME, start-ups and PE backed companies.
Clinical and Scientific Advisory Board
Dr Hadar Lev-Tov-
Advisory Board Member
Hadar Lev-Tov is an Associate Professor at the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller school of Medicine. He is a Board-certified dermatologist with significant interest in wound healing and medical dermatology. His work is supported in part by a career development award from the Dermatology Foundation, the National Institutes of Health, and industry.
Dr. Lev-Tov completed his residency in Dermatology at Albert Einstein College of Medicine in New York City after completing a research post-doctoral training at UC Davis where he also earned his Master’s in clinical research.
Dr. Lev-Tov is the director of the wound healing fellowship at the University of Miami, serves as the President Elect for the HS Foundation board of directors (https://www.hs-foundation.org/), is the founding program chair for the Integrative Dermatology Symposium (https://integrativedermatologysymposium.com/), cohost of the popular “Learnskin podcast” (https://learnskin.libsyn.com/) and is the cofounder of the dermatology-focused educational service Learnskin (https://www.learnskin.com/).